Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intensified Acid Suppression Strategy for Optimizing Helicobacter Pylori Eradication Regimen Duration and Drug Combination: A Multicenter, Open-Label, Randomized Controlled Trial

NCT07750938 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.

NCT NCT07750938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07750938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intensified Acid Suppression Strategy for Optimizing Helicobacter Pylori Eradication Regimen Duration and Drug Combination: A Multicenter, Open-Label, Randomized Controlled Trial
Lead sponsor
Qilu Hospital of Shandong University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
August 10, 2028
Enrollment
316 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infections